MENU
+Compare
BYSI
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.72
Change
+$0.04 (+2.38%)
Capitalization
69.32M

BYSI BeyondSpring Forecast, Technical & Fundamental Analysis

a manufacturer of cancer therapies

Industry Biotechnology
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BYSI with price predictions
Jan 14, 2025

BYSI sees its Stochastic Oscillator ascends from oversold territory

On December 23, 2024, the Stochastic Oscillator for BYSI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 62 instances where the indicator left the oversold zone. In of the 62 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 14, 2025. You may want to consider a long position or call options on BYSI as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BYSI just turned positive on December 20, 2024. Looking at past instances where BYSI's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BYSI advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BYSI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BYSI entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BYSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (87.786). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.852). BYSI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (35.842) is also within normal values, averaging (263.573).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BYSI is expected to report earnings to rise 29.31% to -75 cents per share on July 10

BeyondSpring BYSI Stock Earnings Reports
Q1'23
Est.
$-0.75
Q4'22
Missed
by $0.30
Q3'22
Missed
by $0.21
Q2'22
Missed
by $0.13
Q1'22
Est.
$-0.23
The last earnings report on April 18 showed earnings per share of -57 cents, missing the estimate of -28 cents. With 9.17K shares outstanding, the current market capitalization sits at 69.32M.
A.I. Advisor
published General Information

General Information

a manufacturer of cancer therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
28 Liberty Street
Phone
+1 646 305-6387
Employees
67
Web
https://www.beyondspringpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

BYSI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with PHGE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then PHGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
+2.38%
PHGE - BYSI
40%
Loosely correlated
+0.95%
APGE - BYSI
31%
Poorly correlated
+0.98%
DOSEF - BYSI
27%
Poorly correlated
N/A
XRTX - BYSI
25%
Poorly correlated
-5.84%
EDSA - BYSI
24%
Poorly correlated
+0.60%
More